The European Medicines Agency (EMA) reports on progress to create a smoother, less wasteful biosimilar development process; and the World Health Organization (WHO) revises its biosimilar development ...
The approval of biosimilars in the U.S. is lagging behind that of European countries, a pharmacist said during the American Society of Health-System Pharmacists (ASHP) Midyear virtual meeting. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback